Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies
- PMID: 23557749
- PMCID: PMC3647278
- DOI: 10.1161/JAHA.113.000062
Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies
Abstract
Background: Psoriasis is a chronic inflammatory disease that may be associated with increased risk of cardiovascular events, including cardiovascular mortality, myocardial infarction, and stroke.
Methods and results: We searched the MEDLINE, EMBASE, and Cochrane Central Register databases for relevant studies in English between January 1, 1980, and January 1, 2012. Extraction was by 3 independent reviewers. Summary incidence, risk ratios (RRs), and confidence intervals (CIs) were calculated using fixed-effects and random-effects modeling. Meta-regression was also performed to identify sources of between-study variation. Nine studies were included, representing a total of 201 239 patients with mild and 17 415 patients with severe psoriasis. The level of covariate adjustment varied among studies, leading to the possibility of residual confounding. Using the available adjusted effect sizes, mild psoriasis remained associated with a significantly increased risk of myocardial infarction (RR, 1.29; 95% CI, 1.02 to 1.63) and stroke (RR, 1.12; 95% CI, 1.08 to 1.16). Severe psoriasis was associated with a significantly increased risk of cardiovascular mortality (RR, 1.39; 95% CI, 1.11 to 1.74), myocardial infarction (RR, 1.70; 95% CI, 1.32 to 2.18), and stroke (RR, 1.56 95% CI, 1.32 to 1.84). Based on these risk ratios and the background population event rates, psoriasis is associated with an estimated excess of 11 500 (95% CI, 1169 to 24 407) major adverse cardiovascular events each year.
Conclusions: Mild and severe psoriasis are associated with an increased risk of myocardial infarction and stroke. Severe psoriasis is also associated with an increased risk of cardiovascular mortality. Future studies should include more complete covariate adjustment and characterization of psoriasis severity.
Figures
Similar articles
-
Psoriasis and cardiovascular events: updating the evidence.Arch Dermatol Res. 2017 Apr;309(3):225-228. doi: 10.1007/s00403-016-1712-1. Epub 2017 Feb 17. Arch Dermatol Res. 2017. PMID: 28213804
-
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163. J Eur Acad Dermatol Venereol. 2013. PMID: 23845149 Review.
-
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Health Technol Assess. 2013. PMID: 24074752 Free PMC article. Review.
-
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.J Intern Med. 2011 Aug;270(2):147-57. doi: 10.1111/j.1365-2796.2010.02310.x. Epub 2010 Nov 29. J Intern Med. 2011. PMID: 21114692
-
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. JAMA. 2012. PMID: 22968891 Review.
Cited by
-
The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies.Cureus. 2024 Jun 28;16(6):e63379. doi: 10.7759/cureus.63379. eCollection 2024 Jun. Cureus. 2024. PMID: 38947134 Free PMC article. Review.
-
Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.J Invest Dermatol. 2024 Sep;144(9):1963-1974.e13. doi: 10.1016/j.jid.2024.01.034. Epub 2024 Feb 29. J Invest Dermatol. 2024. PMID: 38431222
-
[Obesity - A Risk Factor for Psoriasis and COVID-19].Actas Dermosifiliogr. 2021 Jun;112(6):489-494. doi: 10.1016/j.ad.2020.12.001. Epub 2020 Dec 24. Actas Dermosifiliogr. 2021. PMID: 34629472 Free PMC article. Review.
-
Neutrophil Pathways of Inflammation Characterize the Blood Transcriptomic Signature of Patients with Psoriasis and Cardiovascular Disease.Int J Mol Sci. 2021 Oct 6;22(19):10818. doi: 10.3390/ijms221910818. Int J Mol Sci. 2021. PMID: 34639156 Free PMC article.
-
Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.JAMA Dermatol. 2015 Feb;151(2):161-9. doi: 10.1001/jamadermatol.2014.2094. JAMA Dermatol. 2015. PMID: 25322196 Free PMC article.
References
-
- Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. The prevalence of psoriasis in African Americans: results from a population‐based study. J Am Acad Dermatol. 2005; 52:23-26 - PubMed
-
- Li K, Armstrong AW. A review of health outcomes in patients with psoriasis. Dermatol Clin. 2012; 30:61-72 - PubMed
-
- Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard‐Lallemand MA, Ortonne JP. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol. 2010; 24suppl 2:23-30 - PubMed
-
- Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009; 122:1150.e1-1150.e9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical